Bifidobacterium longum Subspecies infantis Bacteremia in 3 Extremely Preterm Infants Receiving Probiotics
about
Bifidobacterium: An Emerging Clinically Significant Metronidazole-resistant Anaerobe of Mixed Pyogenic Infections.Bifidobacterium Bacteremia: Clinical Characteristics and a Genomic Approach To Assess Pathogenicity.Probiotics for the prevention of necrotising enterocolitis in very low-birth-weight infants: a meta-analysis and systematic review.
P2860
Bifidobacterium longum Subspecies infantis Bacteremia in 3 Extremely Preterm Infants Receiving Probiotics
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Bifidobacterium longum Subspec ...... m Infants Receiving Probiotics
@en
Bifidobacterium longum Subspec ...... m Infants Receiving Probiotics
@nl
type
label
Bifidobacterium longum Subspec ...... m Infants Receiving Probiotics
@en
Bifidobacterium longum Subspec ...... m Infants Receiving Probiotics
@nl
prefLabel
Bifidobacterium longum Subspec ...... m Infants Receiving Probiotics
@en
Bifidobacterium longum Subspec ...... m Infants Receiving Probiotics
@nl
P2093
P2860
P356
P1476
Bifidobacterium longum Subspec ...... m Infants Receiving Probiotics
@en
P2093
Claus Klingenberg
Eirin Esaiassen
Erik Hjerde
Gunnar S Simonsen
Pauline Cavanagh
Ragnhild Støen
P2860
P304
P356
10.3201/EID2209.160033
P577
2016-09-01T00:00:00Z